Ambrx Biopharma Inc. American Depositary Shares (each representing seven) Recorded Big Gain

Ambrx Biopharma Inc. American Depositary Shares (each representing seven) (AMAM:NYSE) shot up at $12.54, representing a gain of 95%. On Mon, Mar 06, 2023, AMAM:NYSE touched a New 2-Week High of $12.54. The stock got featured on our News Catalysts scanner on Wed, Mar 01, 2023 at 08:53 AM in the 'BIOTECH' category. From Tue, Feb 21, 2023, the stock recorded 55.56% Up Days and 70.00% Green Days
About Ambrx Biopharma Inc. American Depositary Shares (each representing seven) (AMAM:NYSE)
Ambrx Biopharma Inc is a clinical-stage biologics company focused on discovering and developing a novel class of engineered precision biologics (EPBs) using its proprietary expanded genetic code...
Top 10 Gainers:
- Appreciate Holdings Inc Cl A (SFR:NASDAQ), 159.32%
- Unicycive Therapeutics Inc. (UNCY:NASDAQ), 153.06%
- Ambrx Biopharma Inc. American Depositary Shares (each representing seven) (AMAM:NYSE), 95.02%
- Bellerophon Therapeutics, Inc. (BLPH:NASDAQ), 92.86%
- Genelux Corporation (GNLX:NASDAQ), 60.42%
- Orchestra BioMed Holdings Inc Com (OBIO:NASDAQ), 58.09%
- Vallon Pharmaceuticals Inc. (VLON:NASDAQ), 54.64%
- Avalon GloboCare Corp. (ALBT:NASDAQ), 53.92%
- BridgeBio Pharma, Inc. (BBIO:NASDAQ), 51.98%
- Troika Media Group Inc. (TRKA:NASDAQ), 48.64%